[go: up one dir, main page]

FI872807A7 - Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi

Info

Publication number
FI872807A7
FI872807A7 FI872807A FI872807A FI872807A7 FI 872807 A7 FI872807 A7 FI 872807A7 FI 872807 A FI872807 A FI 872807A FI 872807 A FI872807 A FI 872807A FI 872807 A7 FI872807 A7 FI 872807A7
Authority
FI
Finland
Prior art keywords
acylethylaminoalkyl
chromans
dioxanes
preparation
therapeutically active
Prior art date
Application number
FI872807A
Other languages
English (en)
Swedish (sv)
Other versions
FI91064B (fi
FI872807A0 (fi
FI91064C (fi
Inventor
Wolfgang Froestl
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI872807A0 publication Critical patent/FI872807A0/fi
Publication of FI872807A7 publication Critical patent/FI872807A7/fi
Publication of FI91064B publication Critical patent/FI91064B/fi
Application granted granted Critical
Publication of FI91064C publication Critical patent/FI91064C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI872807A 1986-06-26 1987-06-24 Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi FI91064C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH258886 1986-06-26
CH258886 1986-06-26

Publications (4)

Publication Number Publication Date
FI872807A0 FI872807A0 (fi) 1987-06-24
FI872807A7 true FI872807A7 (fi) 1987-12-27
FI91064B FI91064B (fi) 1994-01-31
FI91064C FI91064C (fi) 1994-05-10

Family

ID=4237161

Family Applications (1)

Application Number Title Priority Date Filing Date
FI872807A FI91064C (fi) 1986-06-26 1987-06-24 Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi

Country Status (16)

Country Link
EP (1) EP0252005B1 (fi)
JP (1) JPH0699420B2 (fi)
AT (1) ATE65084T1 (fi)
AU (1) AU617988B2 (fi)
CA (1) CA1322553C (fi)
CY (1) CY1783A (fi)
DD (1) DD279674A5 (fi)
DE (1) DE3771280D1 (fi)
DK (1) DK325587A (fi)
ES (1) ES2044970T3 (fi)
FI (1) FI91064C (fi)
GR (1) GR3002308T3 (fi)
HK (1) HK134994A (fi)
HU (1) HU207061B (fi)
IE (1) IE59881B1 (fi)
PT (1) PT85157B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DK0389425T3 (da) * 1989-03-22 1995-05-22 Ciba Geigy Ag Benzothiopyranylaminer
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2694005B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JP3546657B2 (ja) * 1997-08-29 2004-07-28 株式会社トヨトミ 給湯機の缶体構造
RU2396257C2 (ru) * 2004-12-20 2010-08-10 Ф.Хоффманн-Ля Рош Аг Производные 4-аминопиперидина
WO2016088112A1 (en) 2014-12-05 2016-06-09 Semmelweis University Arylalkylamine compounds for use in the prevention or treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (fr) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Procédé de production de nouveaux dérivés de la pipéridine et de leurs sels
GB1520801A (en) * 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2524887A1 (fr) * 1982-04-08 1983-10-14 Bouchara Emile Nouvelles cyanoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
DE3411993A1 (de) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimittel
JPH0816108B2 (ja) * 1986-02-21 1996-02-21 株式会社クラレ 3,4−ジヒドロ−2h−ベンゾピラン誘導体及びその医薬用途

Also Published As

Publication number Publication date
EP0252005B1 (de) 1991-07-10
DK325587D0 (da) 1987-06-25
DK325587A (da) 1987-12-27
JPS638382A (ja) 1988-01-14
CY1783A (en) 1995-10-20
AU8125587A (en) 1989-05-18
ATE65084T1 (de) 1991-07-15
FI91064B (fi) 1994-01-31
IE59881B1 (en) 1994-04-20
ES2044970T3 (es) 1994-01-16
AU617988B2 (en) 1991-12-12
PT85157A (en) 1987-07-01
FI872807A0 (fi) 1987-06-24
GR3002308T3 (en) 1992-12-30
JPH0699420B2 (ja) 1994-12-07
PT85157B (pt) 1990-03-30
CA1322553C (en) 1993-09-28
EP0252005A1 (de) 1988-01-07
IE871694L (en) 1987-12-26
HUT48622A (en) 1989-06-28
HK134994A (en) 1994-12-09
HU207061B (en) 1993-03-01
FI91064C (fi) 1994-05-10
DD279674A5 (de) 1990-06-13
DE3771280D1 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
FI872379A7 (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
ES518692A0 (es) Metodo de preparacion de derivados farmaceuticamente activosaminoalcoil heterociclicos.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
NO905201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzofuran-derivater.
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
NO872932D0 (no) Fremgangsmaate for fremstilling av proteiner med faktor-viii-aktivitet.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
FI875229A0 (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
FI862795A7 (fi) Menetelmä heterosyklisesti substituoitujen fenoksi-alkyyli-isoksatsolien ja -furaanien valmistamiseksi.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
TR28392A (tr) Seramik bilesikler yapma metodu.
NO874032D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
FI872807A7 (fi) Menetelmä terapeuttisesti vaikuttavien 3-(N-asyylietyyli-aminoalkyyli)-kromaanien ja -1,4-dioksaanien valmistamiseksi
FI874719A7 (fi) Menetelmä 3-pyrrolidinolien valmistamiseksi.
NO875488D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO870998L (no) FremgangsmŸte for fremstilling av nye, terapeutisk aktive acetamid-derivater.
FI874789L (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja
IT8620297A0 (it) Composti stabilizzanti eprocedimento per la loro preparazione.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed
MM Patent lapsed

Owner name: NOVARTIS AG